Briefly, we aimed to identify glycolysis- and lactate-related molecular subtypes and prognostic signature using bioinformatics and statistical analysis, which are highly significant for the prognosis and individualized treatment of COAD patients.
← all excerpts
Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
1
—
—